Advertisement

Effects of Pharmaceuticals on Aquatic Organisms

Keywords

Rainbow Trout Acute Toxicity Fathead Minnow Clofibric Acid Environ Toxicol 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Andersen H, Wollenberger L, Halling-Sørensen B, Kusk K (2001) Development of copepod nauplii to copepodites-A parameter for chronic toxicity including endocrine disruption. Environ Toxicol Chem 20:2821–2829CrossRefGoogle Scholar
  2. Andersen O, Eijsink VGH, Thomassen M (2000) Multiple variants of the peroxisome proliferator-activated receptor (PPAR) gamma are expressed in the liver of Atlantic salmon (Salmo salar). Gene 255:411–418CrossRefGoogle Scholar
  3. Andreozzi R, Raffaele M, Nicklas P (2003) Pharmaceuticals in STP effluents and their solar photodegradation in aquatic environment. Chemosphere 50:1319–1330CrossRefGoogle Scholar
  4. Ankley GT et al. (2002) Evaluation of the aromatase inhibitor fadrozole in a short-term reproduction assay with the fathead minnow (Pimephales promelas). Toxicol Sci 67:121–130CrossRefGoogle Scholar
  5. Ashton D, Hilton M, Thomas KV (2004) Investigating the environmental transport of human pharmaceuticals to streams in the United Kingdom. Sci Total Environ 333:167–184CrossRefGoogle Scholar
  6. Baatrup E, Junge M (2001) Antiandrogenic pesticides disrupt sexual characteristics in the adult male guppy Poecilia reticulata. Environ Health Perspect 109:1063–1070CrossRefGoogle Scholar
  7. Banks AT, Zimmerman HJ, Ishak KG, Harter JG (1995) Diclofenac-associated hepatotoxicity: Analysis of 180 cases reported to the food and drug administration as adverse reactions. Hepatology 22: 820–827Google Scholar
  8. Baronti C, Curini R, D’Ascenzo G, Di Corcia A, Gentili A, Samperi R (2000) Monitoring natural and synthetic estrogens at activated sludge sewage treatment plants and in a receiving river water. Environ Sci Technol 34:5059–5066CrossRefGoogle Scholar
  9. Bjorkman D (1998) Nonsteroidal anti-inflammatory drug-associated toxicity of the liver, lower gastrointestinal tract, and esophagus. Am J Med 105:17S–21SCrossRefGoogle Scholar
  10. Borgmann U, Bennie DT, Ball AL, Palabrica V (2006) Effect of a mixture of seven pharmaceuticals on Hyalella azteca over multiple generations. Chemosphere 66:1278–1283CrossRefGoogle Scholar
  11. Bound JP, Voulvoulis N (2004) Pharmaceuticals in the aquatic environment-a comparison of risk assessment strategies. Chemosphere 56:1143–1155CrossRefGoogle Scholar
  12. Boxall AB, Kolpin DW, Halling-Sørensen B, Tolls J (2003) Are veterinary medicines causing environmental risks? Environ Sci Technol 37:286A–294AGoogle Scholar
  13. Boyd GR, Reemtsma H, Grimm DA, Mitra S (2003) Pharmaceuticals and personal care products (PPCPs) in surface and treated waters of Louisiana, USA and Ontario, Canada. Sci Total Environ. 311:135–149CrossRefGoogle Scholar
  14. Brain RA et al. (2004a) Microcosm evaluation of the effects of an eight pharmaceutical mixture to the aquatic macrophytes Lemna gibba and Myriophyllum sibiricum. Aquat Toxicol 70:23–40CrossRefGoogle Scholar
  15. Brain RA, Johnson DJ, Richards SM, Sanderson H, Sibley PK, Solomon KR (2004b) Effects of 25 pharmaceutical compounds to Lemna gibba using a seven-day static-renewal test. Environ Toxicol Chem 23:371–382CrossRefGoogle Scholar
  16. Brain RA, Reitsma TS, Lissemore LI, Bestari K, Sibley PK, Solomon KR (2006) Herbicidal effects of statin pharmaceuticals in Lemna gibba. Environ Sci Technol 40:5116–5123CrossRefGoogle Scholar
  17. Brian JV et al. (2005) Accurate prediction of the response of freshwater fish to a mixture of estrogenic chemicals. Environ Health Perspect 113:721–728Google Scholar
  18. Brooks BW et al. (2003) Aquatic ecotoxicology of fluoxetine. Toxicol Lett 142:169–183CrossRefGoogle Scholar
  19. Brooks BW et al. (2005) Determination of select antidepressants in fish from an effluent-dominated stream. Environ Toxicol Chem 24:464–469CrossRefGoogle Scholar
  20. Buser HR, Poiger T, Müller MD (1998) Occurrence and fate of the pharmaceutical drug diclofenac in surface waters: rapid photodegradation in a lake. Environ Sci Technol 32:3449–3456CrossRefGoogle Scholar
  21. Buser HR, Poiger T, Müller MD (1999) Occurrence and environmental behavior of the chiral pharmaceutical drug ibuprofen in surface waters and in wastewater. Environ Sci Technol 33:2529–2535CrossRefGoogle Scholar
  22. Cajaraville MP, Cancio M, Ibabe A, Orbea A (2003) Peroxisome proliferation as a biomarker in environmental pollution assessment. Microsc Res Techniq 61:191–202CrossRefGoogle Scholar
  23. Calamari D, Zuccato E, Castiglioni S, Bagnati R, Fanelli R (2003) Strategic survey of therapeutic drugs in the rivers Po and Lambro in northern Italy. Environ Sci Technol 37:1241–1248CrossRefGoogle Scholar
  24. Calleja MC, Persoone G, Geladi P (1993) The predictive potential of a battery of ecotoxicological tests for human acute toxicity, as evaluated with the first 50 MEIC chemicals. ATLA-Altern Lab Anim 21:330–349Google Scholar
  25. Calleja MC, Persoone G, Geladi P (1994) Comparative acute toxicity of the first 50 multicenter evaluations of in-vitro cytotoxicity chemicals to aquatic non-vertebrates. Arch Environ Con Tox 26:69–78CrossRefGoogle Scholar
  26. Caminada D, Escher C, Fent K (2006) Cytotoxicity of pharmaceuticals found in aquatic systems: comparison of PLHC-1 and RTG-2 fish cell lines. Aquat Toxicol 79:114–123CrossRefGoogle Scholar
  27. Carballa M et al. (2004) Behavior of pharmaceuticals, cosmetics and hormones in a sewage treatment plant. Water Res 38:2918–2926CrossRefGoogle Scholar
  28. Clara M, Strenn B, Kreuzinger N (2004) Carbamazepine as a possible anthropogenic marker in the aquatic environment: investigations on the behaviour of carbamazepine in wastewater treatment and during groundwater infiltration. Water Res 38:947–954CrossRefGoogle Scholar
  29. Cleuvers M (2003) Aquatic ecotoxicity of pharmaceuticals including the assessment of combination effects. Toxicol Lett 142:185–194CrossRefGoogle Scholar
  30. Cleuvers M (2004) Mixture toxicity of the anti-inflammatory drugs diclofenac, ibuprofen, naproxen, and acetylsalicylic acid. Ecotox Environ Safe 59:309–315CrossRefGoogle Scholar
  31. Cleuvers M (2005) Initial risk assessment for three [beta]-blockers found in the aquatic environment. Chemosphere 59:199–205CrossRefGoogle Scholar
  32. Cole LM, Lawrence LJ, Casida JE (1984) Similar properties of [35S]-butylbicyclophosphorothionate receptor and coupled components of the gaba receptor-ionophore complex in brains of human, cow, rat, chicken and fish. Life Sci 35:1755–1762CrossRefGoogle Scholar
  33. Cunningham VL, Buzby M, Hutchinson T, Mastrocco FJ, Parke NJ, Roden NM (2006) Effects of human pharmaceuticals on aquatic life: next steps. Environ Sci Technol 40:3456–3462Google Scholar
  34. Damstra T, Barlow S, Bergman A, Kavlock R, van der Kraak G (2002) Global assessment of the state of the science of endocrine disruptors. WHO/PCS/EDC/02.2Google Scholar
  35. Daughton CG, Ternes TA (1999) Pharmaceuticals and personal care products in the environment: agents of subtle change? Environ Health Persp 107:907–938CrossRefGoogle Scholar
  36. De Lange HJ, Noordoven W, Murk AJ, Lüring M, Peeters ETHM (2006) Behavioural responses of Gammarus pulex (Crustacea, Amphipoda) to low concentrations of pharmaceuticals. Aquat Toxicol 78:209–216CrossRefGoogle Scholar
  37. Debernard S, Rossignol F, Couillaud F (1994) HMG-CoA Reductase inhibitor fluvastatin inhibits insect juvenile-hormone biosynthesis. Gen Comp Endocr 95:92–98CrossRefGoogle Scholar
  38. Desbrow C, Routledge EJ, Brighty GC, Sumpter JP, Waldock M (1998) Identification of estrogenic chemicals in STW effluent. 1. Chemical fractionation and in vitro biological screening. Environ Sci Technol 32:1549–1558CrossRefGoogle Scholar
  39. Desvergne B, Wahli W (1999) Peroxisome proliferator-activated receptors: Nuclear control of metabolism. Endocr Rev 20:649–688CrossRefGoogle Scholar
  40. Doggrell SA (1990) The membrane stabilizing and beta1-adrenoceptor blocking activity of (+)- and (–)-propranolol on the rat left atria. Gen Pharmacol Vasc S 21:677–680CrossRefGoogle Scholar
  41. Donohue M, Baldwin LA, Leonard DA, Kostecki PT, Calabrese EJ (1993) Effect of hypolipidemic drugs gemfibrozil, ciprofibrate, and clofibric acid on peroxisomal [beta]-oxidation in primary cultures of rainbow trout hepatocytes. Ecotox Environ Safety 26:127–132CrossRefGoogle Scholar
  42. Dzialowski EM, Brooks BW, Turner PK, Huggett D (2003) Influence of beta-adrenergic blockers on Daphnia magna heart rate, respiration, and reproduction. In: Proceedings of the SETAC North America 23rd Annual Meeting, Austin, USAGoogle Scholar
  43. Emblidge JP, DeLorenzo ME (2006) Preliminary risk assessment of the lipid-regulating pharmaceutical clofibric acid, for three estuarine species. Environ Res 100:216–226CrossRefGoogle Scholar
  44. EMEA (2006) Guideline on the environmental risk assessment of medicinal products for human use. EMEA/CHMP/SWP/4447/00.The European Agency for the evaluation of medicinal products (EMEA), London, 01 June 2006Google Scholar
  45. Escriva H et al. (1997) Ligand binding was acquired during evolution of nuclear receptors. Proc Natl Acad Sci USA 94:6803–6808CrossRefGoogle Scholar
  46. FDA-CDER (1998) Guidance for industry-Environmental assessment of human drugs and biologics applications, Revision 1. FDA Center for Drug Evaluation and Research, RockvilleGoogle Scholar
  47. Fenske M, Maack G, Schafers C, Segner H (2005) An environmentally relevant concentration of estrogen induces arrest of male gonad development in zebrafish, Danio rerio. Environ Toxicol Chem 24:1088–1098CrossRefGoogle Scholar
  48. Fent K (2001) Fish cell lines as versatile tools in ecotoxicology: assessment of cytotoxicity, cytochrome P4501A induction potential and estrogenic activity of chemicals and environmental samples. Toxicol In Vitro 15:477–488CrossRefGoogle Scholar
  49. Fent K (2007) Ökotoxikologie. Georg Thieme Verlag, StuttgartGoogle Scholar
  50. Fent K, Escher C, Caminada D (2006a) Estrogenic activity of pharmaceuticals and pharmaceutical mixtures in a yeast reporter gene system. Reprod Toxicol 22:175–185CrossRefGoogle Scholar
  51. Fent K, Weston AA, Caminada D (2006b) Ecotoxicology of human pharmaceuticals. Aquat Toxicol 76:122–159CrossRefGoogle Scholar
  52. Ferrari B, Paxeus N, Lo Giudice R, Pollio A, Garric J (2003) Ecotoxicological impact of pharmaceuticals found in treated wastewaters: study of carbamazepine, clofibric acid, and diclofenac. Ecotox Environ Safety 55:359–370CrossRefGoogle Scholar
  53. Ferrari B et al. (2004) Environmental risk assessment of six human pharmaceuticals: are the current environmental risk assessment procedures sufficient for the protection of the aquatic environment? Environ Toxicol Chem 23:1344–1354CrossRefGoogle Scholar
  54. Flaherty CM, Kashian DR, Dodson SI (2001) Ecological impacts of pharmaceuticals on zooplankton: effects of three medications on Daphnia magna. In: Annual Meeting of the Society of Environmental Toxicology and Chemistry, BaltimoreGoogle Scholar
  55. Fong PP (1998) Zebra mussel spawning is induced in low concentrations of putative serotonin reuptake inhibitors. Biol Bull 194:143–149CrossRefGoogle Scholar
  56. Fong PP, Huminski PT, D’Urso LM (1998) Induction and potentiation of parturition in fingernail clams (Sphaerium striatum) by selective serotonin re-uptake inhibitors (SSRIs). J Exp Zool 280:260–264CrossRefGoogle Scholar
  57. Foran CM, Weston J, Slattery M, Brooks BW, Duane BH (2004) Reproductive assessment of Japanese Medaka (Oryzias latipes) following a four-week fluoxetine (SSRI) exposure. Arch Environ Contam Toxicol 46:511–517CrossRefGoogle Scholar
  58. Gagne F, Blaise C, André C (2006) Occurrence of pharmaceutical products in a municipal effluent and toxicity to rainbow trout (Oncorhynchus mykiss) hepatocytes. Ecotox Environ Safety 64:329–336CrossRefGoogle Scholar
  59. Gamprel A, Wilkinson M, Boutilier R (1994) B-Adrenoreceptor in the trout heart: characterisation, quantification and effects of repeated catecholamine exposure. Gen Comp Endocrinol 95:259–272CrossRefGoogle Scholar
  60. Gierse JK, Koboldt CM, Walker MC, Seibert K, Isakson PC (1999) Kinetic basis for selective inhibition of cyclo-oxygenases. Biochem J 339:607–614CrossRefGoogle Scholar
  61. Gilbert M et al. (2002) Breeding and mortality of oriental white-backed vulture Gyps bengalensis in Punjab Province, Pakistan. Bird Conserv Int 12:311–326CrossRefGoogle Scholar
  62. Golet EM, Alder AC, Giger W (2002) Environmental exposure and risk assessment of fluoroquinolone antibacterial agents in wastewater and river water of the Glatt valley watershed, Switzerland. Environ Sci Technol 36:3645–3651CrossRefGoogle Scholar
  63. Gravel A, Vijayan MM (2006) Salicylate disrupts interrenal steroidogenesis and brain glucocorticoid receptor expression in rainbow trout. Toxicol Sci 93:41–49CrossRefGoogle Scholar
  64. Haider S, Baqri SSR (2000) beta-Adrenoceptor antagonists reinitiate meiotic maturation in Clarias batrachus oocytes. Comp Biochem Phys A 126:517–525CrossRefGoogle Scholar
  65. Hallare AV, Kohler HR, Triebskorn R (2004) Developmental toxicity and stress protein responses in zebrafish embryos after exposure to diclofenac and its solvent, DMSO. Chemosphere 56:659–666CrossRefGoogle Scholar
  66. Halling-Sørensen B, Nors Nielsen S, Lanzky PF, Ingerslev F, Holten-Lützhøft HC, Jørgensen SE (1998) Occurrence, fate and effects of pharmaceutical substances in the environment-a review. Chemosphere 36:357–393CrossRefGoogle Scholar
  67. Hartmann A, Alder AC, Koller T, Widmer RM (1998) Identification of fluoroquinolone antibiotics as the main source of umuC genotoxicity in native hospital wastewater. Environ Toxicol Chem 17:377–382CrossRefGoogle Scholar
  68. Heberer T (2002) Occurrence, fate, and removal of pharmaceutical residues in the aquatic environment: a review of recent research data. Toxicol Lett 131:5–17CrossRefGoogle Scholar
  69. Henry TB, Kwon J-W, Armbrust KL, Black MC (2004) Acute and chronic toxicity of five selective serotonin reuptake inhibitors in Ceriodaphnia dubia. Environ Toxicol Chem 23:2229–2233CrossRefGoogle Scholar
  70. Henschel KP, Wenzel A, Diedrich M, Fliedner A (1997) Environmental hazard assessment of pharmaceuticals. Regul Toxicol Pharm 25:220–225CrossRefGoogle Scholar
  71. Hernando MD, Petrovic M, Fernandez-Alba AR, Barcelo D (2004) Analysis by liquid chromatographyelectrospray ionization tandem mass spectrometry and acute toxicity evaluation for beta-blockers and lipid-regulating agents in wastewater samples. J Chromatogr A 1046:133–140Google Scholar
  72. Hess R, Staubli W, Riess W (1965) Nature of hepatomegalic effect produced by ethyl-chlorophenoxyisobutyrate in rat. Nature 208:856CrossRefGoogle Scholar
  73. Hirsch R, Ternes T, Haberer K, Kratz KL (1999) Occurrence of antibiotics in the aquatic environment. Sci Total Environ 225:109–118CrossRefGoogle Scholar
  74. Hoeger B, Köllner B, Dietrich DR, Hitzfeld B (2005) Water-borne diclofenac affects kidney and gill integrity and selected immune parameters in brown trout (Salmo trutta f. fario). Aquat Toxicol 75:53–64CrossRefGoogle Scholar
  75. Hoffman BB, Lefkowitz RJ (1998) Katecholamine, Sympathomimetika und Adrenorezeptor-Antagonisten. In: Goodman and Gilman, Pharmakologische Grundlagen der Arzneimitteltherapie. McGraw Hill Deutsche AusgabeGoogle Scholar
  76. Holm JV, Rugge K, Bjerg PL, Christensen TH (1995) Occurrence and distribution of pharmaceutical organic- compounds in the groundwater downgradient of a landfill (Grindsted, Denmark). Environ Sci Technol 29:1415–1420CrossRefGoogle Scholar
  77. Huggett DB, Brooks BW, Peterson B, Foran CM, Schlenk D (2002) Toxicity of selected beta adrenergic receptor-blocking pharmaceuticals (β-blockers) on aquatic organisms. Arch Environ Contam Toxicol 43:229–235CrossRefGoogle Scholar
  78. Hummel D, Löffler D, Fink G, Ternes T (2006) Simultaneous determination of psychoactive drugs and their metabolites in aqueous matrices by liquid chromatography mass spectrometry. Environ Sci Technol 40:7321–7328CrossRefGoogle Scholar
  79. Ibabe A, Grabenbauer M, Baumgart E, Fahimi HD, Cajaraville MP (2002) Expression of peroxisome proliferator-activated receptors in zebrafish (Danio rerio). Histochem Cell Biol 118:231–239Google Scholar
  80. Ibabe A, Herrero A, Cajaraville MP (2005) Modulation of peroxisome proliferator-activated receptors (PPARs) by PPAR[alpha]- and PPAR[gamma]-specific ligands and by 17[beta]-estradiol in isolated zebrafish hepatocytes. Toxicol In Vitro 19:725–735CrossRefGoogle Scholar
  81. Isidori M, Lavorgna M, Nardelli A, Parrella A, Previtera L, Rubino M (2005) Ecotoxicity of naproxen and its phototransformation products. Sci Total Environ 348:91–101Google Scholar
  82. Isidori M, Nardelli A, Parella A, Pascarella L, Previtera L (2006) A multispecies study to assess the toxic and genotoxic effect of pharmaceuticals: Furosemide and its photoproduct. Chemosphere 63:785–793CrossRefGoogle Scholar
  83. Jacob S, Rett K, Henriksen EJ (1998) Antihypertensive therapy and insulin sensitivity: Do we have to redefine the role of beta-blocking agents? Am J Hypertens 11:1258–1265CrossRefGoogle Scholar
  84. Jensen KM et al. (2004) Characterization of responses to the antiandrogen flutamide in a short-term reproduction assay with the fathead minnow. Aquat Toxicol 70:99–110CrossRefGoogle Scholar
  85. Jones OA, Voulvoulis N, Lester JN (2002) Aquatic environmental assessment of the top 25 English prescription pharmaceuticals. Water Res 36:5013–5022CrossRefGoogle Scholar
  86. Kersten S, Desvergne B, Wahli W (2000) Roles of PPARs in health and disease. Nature 405:421–424CrossRefGoogle Scholar
  87. Kliewer SA et al. (1997) Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma. Proc Natl Acad Sci USA 94:4318–4323CrossRefGoogle Scholar
  88. Kolpin DW et al. (2002) Pharmaceuticals, hormones, and other organic wastewater contaminants in U.S. streams, 1999–2000: a national reconnaissance. Environ Sci Technol 36:1202–1211CrossRefGoogle Scholar
  89. Kümmerer K (2001) Drugs in the environment: emission of drugs, diagnostic aids and disinfectants into wastewater by hospitals in relation to other sources – a review. Chemosphere 45:957–969CrossRefGoogle Scholar
  90. Kümmerer K (ed) (2004) Pharmaceuticals in the environment, 2nd edn. Springer-Verlag, BerlinGoogle Scholar
  91. Kümmerer K, Steger-Hartmann T, Meyer M (1997) Biodegradability of the anti-tumour agent ifosfamide and its occurrence in hospital effluents and communal sewage. Water Res 31:2705–2710CrossRefGoogle Scholar
  92. Kurumbail RG et al. (1997) Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents. Nature 385:555Google Scholar
  93. Lönge R, Hutchinson TH, Croudace CP, Siegmund F (2001) Effects of the synthetic estrogen 17 alphaethinylestradiol on the life-cycle of the fathead minnow (Pimephales promelas). Environ Toxicol Chem 20:1216–1227CrossRefGoogle Scholar
  94. Laufs U, Liao JK (1998) Post-transcriptional regulation of endothelial nitric oxide synthase mRNA stability by Rho GTPase. J Biol Chem 273:24266–24271CrossRefGoogle Scholar
  95. Laville N, Ait-Aissa S, Gomez E, Casellas C, Porcher JM (2004) Effects of human pharmaceuticals on cytotoxicity, EROD activity and ROS production in fish hepatocytes. Toxicology 196:41–55CrossRefGoogle Scholar
  96. Leaver MJ, Wright J, George SG (1998) A peroxisomal proliferator-activated receptor gene from the marine flatfish, the plaice (Pleuronectes platessa). Mar Environ Res 46:75–79CrossRefGoogle Scholar
  97. Lilius H, Isomaa B, Holmstrom T (1994) A comparison of the toxicity of 50 reference chemicals to freshly isolated rainbow trout hepatocytes and Daphnia magna. Aquat Toxicol 30:47–60CrossRefGoogle Scholar
  98. Lundholm CE (1997) DDE-induced eggshell thinning in birds: Effects of p,p’-DDE on the calcium and prostaglandin metabolism of the eggshell gland. Comp Biochem Phys C 118:113–128Google Scholar
  99. MacDonald RL, Olsen RW (1994) GABA A receptor channels. Ann Rev Neurosci 17:569–602Google Scholar
  100. Marques CR, Abrantes N, Goncalves F (2004) Life-history traits of standard and autochthonous cladocerans: I. Acute and chronic effects of acetylsalicylic acid. Environ Toxicol 19:518–526CrossRefGoogle Scholar
  101. Meissl H, Ekstrom P (1991) Action of gamma-aminobutyric-acid (GABA) in the isolated photosensory pineal organ. Brain Res 562:71–78CrossRefGoogle Scholar
  102. Metcalfe CD, Miao XS, Koenig BG, Struger J (2003) Distribution of acidic and neutral drugs in surface waters near sewage treatment plants in the lower Great Lakes, Canada. Environ Toxicol Chem 22:2881–2889CrossRefGoogle Scholar
  103. Mimeault C, Woodhouse AJ, Miao XS, Metcalfe CD, Moon TW, Trudeau VL (2005) The human lipid regulator, gemfibrozil bioconcentrates and reduces testosterone in the goldfish, Carassius auratus. Aquat Toxicol 73:44–54CrossRefGoogle Scholar
  104. Mimeault C, Trudeau VL, Moon TW (2006) Waterborne gemfibroil challenges the hepatic antioxidant defense system and down-regulates peroxisome proliferator-activated recepor beta (PPARb) mRNA levels in male goldfish (Carassius auratus). Toxicology 228:140–150CrossRefGoogle Scholar
  105. Montforts MHMM, Kalf DF, van Vlaardingen PLA, Linders JBHJ (1999) The exposure assessment for veterinary medicinal products. Sci Total Environ 225:119–133CrossRefGoogle Scholar
  106. Nash JP et al. (2004) Long-term exposure to environmental concentrations of the pharmaceutical ethynylestradiol causes reproductive failure in fish. Environ Health Perspect 112:1725–1733Google Scholar
  107. Nation JL (2002) Insect physiology and biochemistry. CRC Press, Boca RatonGoogle Scholar
  108. Navarro I et al. (1999) Insulin, insulin-like growth factor-I (IGF-I) and glucagon: the evolution of their receptors. Comp Biochem Phys B 122:137–153CrossRefGoogle Scholar
  109. Nelson DR et al. (1996) P450 superfamily: Update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics 6:1–42CrossRefGoogle Scholar
  110. Nickerson JG, Dugan SG, Drouin G, Moon TW (2001) A putative beta-adrenoceptor from the rainbow trout (Oncorhynchus mykiss). Molecular charcterisation and pharmacology. Eur J Biochem 268: 6465–6472CrossRefGoogle Scholar
  111. Nunes B, Carvalho F, Guilhermino L (2004) Acute and chronic effects of clofibrate and clofibric acid on the enzymes acetylcholinesterase, lactate dehydrogenase and catalase of the mosquitofish, Gambusia holbrooki. Chemosphere 57:1581–1589CrossRefGoogle Scholar
  112. Oaks JL et al. (2004) Diclofenac residues as the cause of vulture population decline in Pakistan. Nature 427:630–633CrossRefGoogle Scholar
  113. Pagano G et al. (2001) The role of oxidative stress in developmental and reproductive toxicity of tamoxifen. Life Sci 68:1735–1749CrossRefGoogle Scholar
  114. Panter GH, Hutchinson TH, Hurd KS, Sherren A, Stanley RD, Tyler CR (2004) Successful detection of (anti-) androgenic and aromatase inhibitors in pre-spawning adult fathead minnows (Pimephales promelas) using easily measured endpoints of sexual development. Aquat Toxicol 70:11–21CrossRefGoogle Scholar
  115. Parrott JL, Blunt BR (2005) Life-cycle exposure of fathead minnows (Pimephales promelas) to an ethinylestradiol concentration below 1 ng l–1 reduces egg fertilization success and demasculinizes males. Environ Toxicol 20:131–141CrossRefGoogle Scholar
  116. Pascoe D, Karntanut W, Muller CT (2003) Do pharmaceuticals affect freshwater invertebrates? A study with the cnidarian Hydra vulgaris. Chemosphere 51:521–528CrossRefGoogle Scholar
  117. Pawlowski S, van Aerle R, Tyler CR, Braunbeck T (2004) Effects of 17α-ethinylestradiol in a fathead minnow (Pimephales promelas) gonadal recrudescence assay. Ecotoxicol Environ Safety 57:330–345CrossRefGoogle Scholar
  118. Pedibhotla VK, Sarath G, Sauer JR, Stanleysamuelson DW (1995) Prostaglandin biosynthesis and subcellular- localization of prostaglandin-H synthase activity in the lone star tick, Amblyommaamericanum. Insect Biochem Molec 25:1027–1039CrossRefGoogle Scholar
  119. Penning TD et al. (1997) Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors: Identification of 4- 5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol- 1-yl benzenesulfonamide (SC-58635, Celecoxib). J Med Chem 40:1347–1365CrossRefGoogle Scholar
  120. Peraza MA, Burdick AD, Marin HE, Gonzalez FJ, Peters JM (2006) The toxicology of ligands for peroxisome proliferator-activated receptors (PPAR). Toxicol Sci 90:269–295CrossRefGoogle Scholar
  121. Qu B, Li Q-T, Wong KP, Tan TMC, Halliwell B (2001) Mechanism of clofibrate hepatotoxicity: mitochondrial damage and oxidative stress in hepatocytes. Free Radical Biol Med 31:659–669CrossRefGoogle Scholar
  122. Rang HP, Dale MM, Ritter JM (2003) Pharmacology. Churchill LivingstoneGoogle Scholar
  123. Rau MA, Whitaker J, Freedman JH, Di Giulio RT (2004) Differential susceptibility of fish and rat liver cells to oxidative stress and cytotoxicity upon exposure to prooxidants. Comp Biochem Phys C 137:335–342Google Scholar
  124. Richards SM et al. (2004) Effects of pharmaceutical mixtures in aquatic microcosms. Environ Toxicol Chem 23:1035–1042CrossRefGoogle Scholar
  125. Roberts SB, Langenau DM, Goetz FW (2000) Cloning and characterization of prostaglandin endoperoxide synthase-1 and -2 from the brook trout ovary. Mol Cell Endocrin 160:89–97CrossRefGoogle Scholar
  126. Rogers CJ, Twyman RE, Macdonald RL (1994) Benzodiazepine and beta-carboline regulation of single GABA A receptor channels of mouse spinal neurones in culture. J Physiol 475:69–82Google Scholar
  127. Ruuskanen JO, Peitsaro N, Kaslin JV, Panula P, Scheinin M (2005) Expression and function of α-adrenoceptors in zebrafish: drug effects, mRNA and receptor distributions. Brti J Pharmacol 144:165–177CrossRefGoogle Scholar
  128. Ruyter B, Andersen O, Dehli A, Ostlund Farrants A-K, Gjoen T, Thomassen MS (1997) Peroxisome proliferator activated receptors in Atlantic salmon (Salmo salar): effects on PPAR transcription and acyl-CoA oxidase activity in hepatocytes by peroxisome proliferators and fatty acids. BBA-Lipid Met 1348:331–338CrossRefGoogle Scholar
  129. Sanderson H, Johnson DJ, Wilson CJ, Brain RA, Solomon KR (2003) Probabilistic hazard assessment of environmentally occurring pharmaceuticals toxicity to fish, daphnids and algae by ECOSAR screening. Toxicol Lett 144:383–395CrossRefGoogle Scholar
  130. Sanderson H, Brain RA, Johnson DJ, Wilson CJ, Solomon KR (2004a) Toxicity classification and evaluation of four pharmaceuticals classes: antibiotics, antineoplastics, cardiovascular, and sex hormones. Toxicology 203:27–40CrossRefGoogle Scholar
  131. Sanderson H, Johnson DJ, Reitsma T, Brain RA, Wilson CJ, Solomon KR (2004b) Ranking and prioritization of environmental risks of pharmaceuticals in surface waters. Regul Toxicol Pharm 39:158–183CrossRefGoogle Scholar
  132. Scarano LJ, Calabrese EJ, Kostecki PT, Baldwin LA, Leonard DA (1994) Evaluation of a rodent peroxisome proliferator in two species of freshwater fish: rainbow trout (Onchorynchus mykiss) and Japanese medaka (Oryzias latipes). Ecotoxicol Environ Safety 29:13–19CrossRefGoogle Scholar
  133. Schalhorn A (1995) Medikamentöse Therapie maligner Erkrankungen. Gustav Fischer Verlag, StuttgartGoogle Scholar
  134. Scholze J (1999) Hypertonie – Risikokonstellationen und Begleiterkrankungen. BlackwellGoogle Scholar
  135. Schoonjans K, Staels B, Auwerx J (1996) Role of the peroxisome proliferator-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression. J Lipid Res 37:907–925Google Scholar
  136. Schwaiger J, Ferling H, Mallow U, Wintermayr H, Negele RD (2004) Toxic effects of the non-steroidal anti-inflammatory drug diclofenac. Part I: Histopathological alterations and bioaccumulation in rainbow trout. Aquat Toxicol 68:141–150Google Scholar
  137. Song WC, Brash AR (1991) Purification of an allene oxide synthase and identification of the enzyme as a cytochrome-P-450. Science 253:781–784CrossRefGoogle Scholar
  138. Soyka D (1984) Beta-blockers in the prophylactic treatment of migraine and tension headache. Nervenheilkunde 3:85–89Google Scholar
  139. Soyka D (1985) Beta-receptor blockers in migraine. Deut Med Wochenschr 110:185–186Google Scholar
  140. Staels B, Dallongeville J, Auwerx J, Schoonjans K, Leitersdorf E, Fruchart J-C (1998) Mechanism of action of fibrates on lipid and lipoprotein metabolism. Circulation 98:2088–2093Google Scholar
  141. Straub JO (2002) Environmental risk assessment for new human pharmaceuticals in the European Union according to the draft guideline/discussion paper of January 2001. Toxicol Lett 135:231–237CrossRefGoogle Scholar
  142. Straub JO, Stewart KM (2007) Deterministic and probabilistic acute-based environmental risk assessment for naproxen for western Europe. Environ Toxicol Chem 26:795–805CrossRefGoogle Scholar
  143. Study RE, Barker JL (1981) Diazepam and (-)-pentobarbital: fluctuation analysis reveals different mechanisms for potentiation of gamma-aminobutyric acid responses in cultured central neurons. Proc Natl Acad Sci USA 78:7180–7184CrossRefGoogle Scholar
  144. Stumpf M, Ternes T, Haberer K, Seel P, Baumann W (1996) Nachweis von Arzneimittelrückstönden in Klöranlagen und Fliessgewössern. Vom Wasser 86:291–303Google Scholar
  145. Stumpf M, Ternes TA, Wilken R-D, Silvana Vianna Rodrigues, Baumann W (1999) Polar drug residues in sewage and natural waters in the state of Rio de Janeiro, Brazil. Sci Total Environ 225:135–141Google Scholar
  146. Ternes TA (1998b) Occurrence of drugs in German sewage treatment plants and rivers. Water Res 32:3245–3260CrossRefGoogle Scholar
  147. Ternes T, Hirsch R, Mueller J, Haberer K (1998a) Methods for the determination of neutral drugs as well as betablockers and alpha2-sympathomimetics in aqueous matrices using GC/MS and LC/MS/MS. Fresen J Anal Chem 362:329–340CrossRefGoogle Scholar
  148. Ternes TA, Stumpf M, Mueller J, Haberer K, Wilken R-D, Servos M (1999) Behavior and occurrence of estrogens in municipal sewage treatment plants I. Investigations in Germany, Canada and Brazil. Sci Total Environ 225:81–90CrossRefGoogle Scholar
  149. Ternes T, Bonerz M, Schmidt T (2001) Determination of neutral pharmaceuticals in wastewater and rivers by liquid chromatography-electrospray tandem mass spectrometry. J Chromatogr A 938:175–185CrossRefGoogle Scholar
  150. Ternes T, Jos A, Siegrist H (2004) Scrutinizing pharmaceutical and personal care products in wastewater treatment. Environ Sci Technol 38:393–399CrossRefGoogle Scholar
  151. Thaker (2005) Pharmaceutical data elude researchers. Environ Sci Technol 139:193A–194AGoogle Scholar
  152. Thomas KV, Hilton MJ (2004) The occurrence of selected human pharmaceutical compounds in UK estuaries. Mar Pollut Bull 49:436–444CrossRefGoogle Scholar
  153. Triebskorn R, Casper H, Heyd A, Eikemper R, Kohler H-R, Schwaiger J (2004) Toxic effects of the nonsteroidal anti-inflammatory drug diclofenac: Part II. Cytological effects in liver, kidney, gills and intestine of rainbow trout (Oncorhynchus mykiss). Aquat Toxicol 68:151–166CrossRefGoogle Scholar
  154. van der Ven K, Keil D, Van Leemput K, van Remortel P, De Coen WM (2006) Neuropharmaceuticals in the environment: mianserin-induced neuroendocrine disruption in zebrafish (Danio rerio) using cDNA microarrays. Environ Toxicol Chem 25:2645–2652CrossRefGoogle Scholar
  155. Vane JR, Botting RM (1998) Mechanism of action of anti-inflammatory drugs. Int J Tissue React 20:3–15Google Scholar
  156. Villegas-Navarro A, Rosas-L E, Reyes JL (2003) The heart of Daphnia magna: effects of four cardioactive drugs. Comp Biochem Phys C 136:127–134CrossRefGoogle Scholar
  157. Wallace JL (1997) Nonsteroidal anti-inflammatory drugs and gastroenteropathy: the second hundred years. Gastroenterology 112:1000–1016CrossRefGoogle Scholar
  158. Wallace JL, McKnight W, Reuter BK, Vergnolle N (2000) NSAID-induced gastric damage in rats: requirement for inhibition of both cyclooxygenase 1 and 2. Gastroenterology 119:706–714CrossRefGoogle Scholar
  159. Webb SF (2001) A data based perspective on the environmental risk assessment of human pharmaceuticals II: aquatic risk characterisation. In: Kümmerer K (ed) Pharmaceuticals in the environment. Sources, fate, effects and risks, 1st edn. Springer-Verlag Berlin, Heidelberg, New York, pp 319–343Google Scholar
  160. Webb SF (2004) A data-based perspective on the environmental risk assessment of human pharmaceuticals I – collation of available ecotoxicity data. In: Kümmerer K (ed) Pharmaceuticals in the environment, 2nd edn. Springer-Verlag, Berlin, Heidelberg, New York, pp 317–343Google Scholar
  161. Weigel S, Kuhlmann J, Huhnerfuss H (2002) Drugs and personal care products as ubiquitous pollutants: occurrence and distribution of clofibric acid, caffeine and DEET in the North Sea. Sci Total Environ 295:131–141CrossRefGoogle Scholar
  162. Weigel S, Berger U, Jensen E, Kallenborn R, Thoresen H, Hühnerfuss H (2004) Determination of selected pharmaceuticals and caffeine in sewage and seawater from Tromso/Norway with emphasis on ibuprofen and its metabolites. Chemosphere 56:583–592CrossRefGoogle Scholar
  163. Wiegel S et al. (2004) Pharmaceuticals in the river Elbe and its tributaries. Chemosphere 57:107–126CrossRefGoogle Scholar
  164. Wilson VS et al. (2004) Cloning and in vitro expression and characterization of the androgen receptor and isolation of estrogen receptor alpha from the fathead minnow (Pimephales promelas). Environ Sci Technol 38:6314–6321Google Scholar
  165. Yang S, Carlson K (2004) Routine monitoring of antibiotics in water and wastewater with a radioimmunoassay technique. Water Res 38:3155–3166CrossRefGoogle Scholar
  166. Zou J et al. (1999) Fish macrophages express a cyclo-oxygenase-2 homologue after activation. Biochem J 340:153–159CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2008

Authors and Affiliations

  • K. Fent
    • 1
  1. 1.Northwestern Switzerland School of Life Sciences and Swiss Federal Institute of Technology Zürich (ETHZ)University of Applied SciencesSwitzerland

Personalised recommendations